Sunovion Pharmaceuticals VP of Finance Salary | Comparably
Sunovion Pharmaceuticals Inc. engages in discovering, developing, and commercializing therapeutic products for patients suffering from read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
175

Sunovion Pharmaceuticals VP of Finance Salary

The average Sunovion Pharmaceuticals VP of Finance earns an estimated $147,200 annually. Sunovion Pharmaceuticals' VP of Finance compensation is $59,329 less than the US average for a VP of Finance.

The Finance Department at Sunovion Pharmaceuticals earns $20,410 more on average than the Admin Department.

Last updated 3 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$147,200
Average Compensation
$147,200
avg. base

VP of Finance Salaries at Sunovion Pharmaceuticals

VPs of Finance earn $46,373 more than Accounting Managers.

Accounting Manager
$101k*
Financial Analyst
$92k*
Senior Accountant
$90k*
Business Analyst
$73k*
Accountant
$63k*
* estimated salary

Compensation at Sunovion Pharmaceuticals by Department

The Finance Department averages $20,410 more than the Admin Department, and $5,313 less than the Business Development Department

Business Development
$80,977 Avg. total comp.
+$5k
Finance
$75,664 Avg. total comp.
Admin
$55,254 Avg. total comp.
-$20k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to Sunovion Pharmaceuticals reported making $177,100, while the average male VP of Finance at similar sized companies reported making $215,104.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to Sunovion Pharmaceuticals reported making $200,133, while the average Asian or Pacific Islander VP of Finance at similar sized companies reported making $159,667.

How VPs of Finance at Sunovion Pharmaceuticals Rate Their Compensation

The majority of VPs of Finance at Sunovion Pharmaceuticals believe they're not compensated fairly. 67% of VPs of Finance at Sunovion Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Sunovion Pharmaceuticals

×
Rate your company